Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic analysis of asthma practices.

D A Stempel

    The American Journal of Managed Care
    |February 24, 2001
    PubMed
    Summary

    Selecting asthma treatments requires evaluating scientific evidence, clinical trials, and real-world economic data. The best controller therapy improves lung function and outcomes with minimal side effects and cost-effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Should asthma control be the guide for therapeutic decision-making?

    Allergy·2007
    Same author

    Adherence to asthma controller medication regimens.

    Respiratory medicine·2005
    Same author

    Asthma variability.

    The European respiratory journal·2003
    Same author

    Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up.

    Respiratory medicine·2002
    Same author

    Is there hope in studies demonstrating an increase in asthma prevalence?

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2001
    Same author

    Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.

    Respiratory medicine·2001

    Area of Science:

    • Pulmonology
    • Pharmacoeconomics
    • Clinical Trial Analysis

    Background:

    • Asthma treatment decisions require integrating diverse evidence.
    • Selecting optimal therapies balances efficacy, safety, and cost.

    Purpose of the Study:

    • To outline a framework for selecting first-line and add-on asthma controller therapies.
    • To emphasize the importance of combining basic science, clinical trial, and real-world economic data.

    Main Methods:

    • Review of evidence supporting therapeutic agents.
    • Analysis of randomized controlled trials (RCTs) for efficacy and safety.
    • Evaluation of retrospective claims analyses for real-world economic impact.

    Main Results:

    • No single first-line controller may universally achieve all desired outcomes.
    • A comprehensive data review is crucial for informed treatment selection.
    • Economic evidence confirms basic science and clinical findings.

    Conclusions:

    • Clinicians must consider basic science, RCTs, and economic data for asthma treatment.
    • Optimal therapy selection involves assessing lung function, patient outcomes, adverse effects, and cost-effectiveness.
    • Evaluating add-on therapies requires similar rigorous, multi-faceted analysis.

    Related Experiment Videos